The broad market index advanced 0.72% to close at 5,886.55. The S&P 500 now has a gain of 0.08% in 2025. The Nasdaq Composite ...

People with multiple long-term physical health conditions are at a significantly greater risk of developing depression, a study shows.

People with multiple long-term physical health conditions are at a significantly greater risk of developing depression, a ...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...